Skip to main content
SpringerLink
Log in

Noninvasive, Minimally Invasive, and Surgical Pearls for Cosmetic Rejuvenation of the Thyroid Eye Disease Patient

  • Chapter
  • First Online:
Thyroid Eye Disease

  • 1433 Accesses

Abstract

Although clinicians will easily recall the classic picture of thyroid eye disease (TED) as a patient with red, bulging, misaligned eyes, the disease is distinctly heterogeneous and most patients are more mildly affected. Whether severe or not, patients are often deeply affected by these alterations in their appearance. Historically, surgical rehabilitation has been offered only in the most severe cases and focused primarily on the functional goals of reducing proptosis, strabismus and lid retraction. This concentration tends to neglect a range of patients who do not fit classic anatomic or physiologic indications. Further, many techniques tend to neglect subtleties of cosmetic rejuvenation in these severely affected individuals. This chapter outlines a holistic view of cosmetic rejuvenation and includes a range of noninvasive and minimally invasive techniques appropriate for patients with milder and active inflammatory disease, who may not fit classic indications for surgery. Additionally, some insights are offered regarding aesthetic considerations for decompression, strabismus, and lid retraction surgery.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Elberling TV, Rasmussen AK, Feldt-Rasmussen U, Hørding M, Perrild H, Waldemar G. Impaired health-related quality of life in Graves’ disease. A prospective study. Eur J Endocrinol. 2004;151:549–55.

    Article  CAS  PubMed  Google Scholar 

  2. Gerding MN, Terwee CB, Dekker FW, Koornneef L, Prummel MF, Wiersinga WM. Quality of life in patients with Graves’ ophthalmopathy is markedly decreased: measurement by the medical outcomes study instrument. Thyroid. 1997;7:885–9.

    Article  CAS  PubMed  Google Scholar 

  3. Kahaly GJ, Petrak F, Hardt J, Pitz S, Egle UT. Psychosocial morbidity of Graves’ orbitopathy. Clin Endocrinol (Oxf). 2005;63:395–402.

    Article  CAS  Google Scholar 

  4. Park JJ, Sullivan TJ, Mortimer RH, Wagenaar M, Perry-Keene DA. Assessing quality of life in Australian patients with Graves’ ophthalmopathy. Br J Ophthalmol. 2004;88:75–8.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  5. Terwee C, Wakelkamp I, Tan S, Dekker F, Prummel MF, Wiersinga W. Long-term effects of Graves’ ophthalmopathy on health-related quality of life. Eur J Endocrinol. 2002;146:751–7.

    Article  CAS  PubMed  Google Scholar 

  6. Wiersinga W, Prummel M, Terwee C. Effects of Graves’ ophthalmopathy on quality of life. J Endocrinol Invest. 2004;27:259–64.

    Article  CAS  PubMed  Google Scholar 

  7. Ponto KA, Pitz S, Pfeiffer N, Hommel G, Weber MM, Kahaly GJ. Quality of life and occupational disability in endocrine orbitopathy. Dtsch Arztebl Int. 2009;106:283–9.

    PubMed Central  PubMed  Google Scholar 

  8. Bartley GB, Fatourechi V, Kadrmas EF, et al. Long-term follow-up of Graves ophthalmopathy in an incidence cohort. Ophthalmology. 1996;103:958–62.

    Article  CAS  PubMed  Google Scholar 

  9. Coulter I, Frewin S, Krassas GE, Perros P. Psychological implications of Graves’ orbitopathy. Eur J Endocrinol. 2007;157:127–31.

    Article  CAS  PubMed  Google Scholar 

  10. Jensen AL, Harder I. The impact of bodily change on social behaviour in patients with thyroid-associated ophthalmopathy. Scand J Caring Sci. 2011;25:341–9.

    Article  PubMed  Google Scholar 

  11. Estcourt S, Hickey J, Perros P, Dayan C, Vaidya B. The patient experience of services for thyroid eye disease in the United Kingdom: results of a nationwide survey. Eur J Endocrinol. 2009;161:483–7.

    Article  CAS  PubMed  Google Scholar 

  12. Estcourt S, Vaidya B, Quinn A, Shepherd M. The impact of thyroid eye disease upon patients’ wellbeing: a qualitative analysis. Clin Endocrinol (Oxf). 2008;68:635–9.

    Article  Google Scholar 

  13. Rice G, Ingram J, Mizan J. Enhancing a primary care environment: a case study of effects on patients and staff in a single general practice. Br J Gen Pract. 2008;58:465–70.

    Article  PubMed  Google Scholar 

  14. Dijkstra K, Pieterse M, Pruyn A. Physical environmental stimuli that turn healthcare facilities into healing environments through psychologically mediated effects: systematic review. J Adv Nurs. 2006;56:166–81.

    Article  PubMed  Google Scholar 

  15. Drahota A, Ward D, Mackenzie H, et al. Sensory environment on health-related outcomes of hospital patients. Cochrane Database Syst Rev. 2012;3, CD005315.

    PubMed  Google Scholar 

  16. Altiparmak UE, Acar DE, Ozer PA, et al. Topical cyclosporine A for the dry eye findings of thyroid orbitopathy patients. Eye (Lond). 2010;24:1044–50.

    Article  CAS  Google Scholar 

  17. Sokol JA, Foulks GN, Haider A, Nunery WR. Ocular surface effects of thyroid disease. Ocul Surf. 2010;8:29–39.

    Article  PubMed  Google Scholar 

  18. Lee H, Roh HS, Yoon JS, Lee SY. Assessment of quality of life and depression in Korean patients with Graves’ ophthalmopathy. Korean J Ophthalmol. 2010;24:65–72.

    Article  PubMed Central  PubMed  Google Scholar 

  19. Shorr N, Seiff SR. The four stages of surgical rehabilitation of the patient with dysthyroid ophthalmopathy. Ophthalmology. 1986;93:476–83.

    Article  CAS  PubMed  Google Scholar 

  20. Jackson JL. Nonsurgical management of diplopia after orbital decompression surgery. Am Orthopt J. 2012;62:29–33.

    Article  PubMed  Google Scholar 

  21. Rutstein RP. Use of Bangerter filters with adults having intractable diplopia. Optometry. 2010;81:387–93.

    Article  PubMed  Google Scholar 

  22. Fraine L. Nonsurgical management of diplopia. Am Orthopt J. 2012;62:13–8.

    Article  PubMed  Google Scholar 

  23. Wu X, Lin N, Ai LK, Wang JH, Yan LJ. The application of botulinum toxin A in the treatment of restrictive strabismus in thyroid associated ophthalmopathy. Zhonghua Yan Ke Za Zhi. 2006;42:1063–7.

    CAS  PubMed  Google Scholar 

  24. Gair EJ, Lee JP, Khoo BK, Maurino V. What is the role of botulinum toxin in the treatment of dysthyroid strabismus? J AAPOS. 1999;3:272–4.

    Article  CAS  PubMed  Google Scholar 

  25. Lyons CJ, Vickers SF, Lee JP. Botulinum toxin therapy in dysthyroid strabismus. Eye (Lond). 1990;4(Pt 4):538–42.

    Article  Google Scholar 

  26. Bunevicius R, Velickiene D, Prange Jr AJ. Mood and anxiety disorders in women with treated hyperthyroidism and ophthalmopathy caused by Graves’ disease. Gen Hosp Psychiatry. 2005;27:133–9.

    Article  PubMed  Google Scholar 

  27. Farid M, Roch-Levecq AC, Levi L, Brody BL, Granet DB, Kikkawa DO. Psychological disturbance in graves ophthalmopathy. Arch Ophthalmol. 2005;123:491–6.

    Article  PubMed  Google Scholar 

  28. Pfeilschifter J, Ziegler R. Smoking and endocrine ophthalmopathy: impact of smoking severity and current vs lifetime cigarette consumption. Clin Endocrinol (Oxf). 1996;45:477–81.

    Article  CAS  Google Scholar 

  29. Bartalena L, Marcocci C, Tanda ML, et al. Cigarette smoking and treatment outcomes in Graves ophthalmopathy. Ann Intern Med. 1998;129:632–5.

    Article  CAS  PubMed  Google Scholar 

  30. Eckstein A, Quadbeck B, Mueller G, et al. Impact of smoking on the response to treatment of thyroid associated ophthalmopathy. Br J Ophthalmol. 2003;87:773–6.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  31. Stead L, Buitrago D, Preciado N, Sanchez G, Lancaster T. Physician advice for smoking cessation (Review). Cochrane Database Syst Rev. 2013;31.

    Google Scholar 

  32. Mills EJ, Wu P, Lockhart IAN, Thorlund K, Puhan M, Ebbert JONO. Comparisons of high-dose and combination nicotine replacement therapy, varenicline, and bupropion for smoking cessation: A systematic review and multiple treatment meta-analysis. Ann Med. 2012;44:588–97.

    Article  CAS  PubMed  Google Scholar 

  33. Suls JM, Luger TM, Curry SJ, Mermelstein RJ, Sporer AK, An LC. Efficacy of smoking-cessation interventions for young adults: a meta-analysis. Am J Prev Med. 2012;42:655–62.

    Article  PubMed Central  PubMed  Google Scholar 

  34. Tahiri M, Mottillo S, Joseph L, Pilote L, Eisenberg MJ. Alternative smoking cessation aids: a meta-analysis of randomized controlled trials. Am J Med. 2012;125:576–84.

    Article  PubMed  Google Scholar 

  35. Zbikowski SM, Magnusson B, Pockey JR, Tindle HA, Weaver KE. A review of smoking cessation interventions for smokers aged 50 and older. Maturitas. 2012;71:131–41.

    Article  PubMed  Google Scholar 

  36. Werner SC. Classification of the eye changes of Graves’ disease. Am J Ophthalmol. 1969;68:646–8.

    Article  CAS  PubMed  Google Scholar 

  37. Mourits MP, Prummel MF, Wiersinga WM, Koornneef L. Clinical activity score as a guide in the management of patients with Graves’ ophthalmopathy. Clin Endocrinol (Oxf). 1997;47:9–14.

    Article  CAS  Google Scholar 

  38. Dolman PJ, Rootman J. VISA classification for Graves orbitopathy. Ophthal Plast Reconstr Surg. 2006;22:319–24.

    Article  PubMed  Google Scholar 

  39. Goldberger S, Sarraf D, Bernstein JM, Hurwitz JJ. Involvement of the eyebrow fat pad in Graves’ orbitopathy. Ophthal Plast Reconstr Surg. 1994;10:80–6.

    Article  CAS  PubMed  Google Scholar 

  40. Papageorgiou K, Hwang C. Thyroid-associated periorbitopathy eyebrow fat and soft tissue expansion in patients with thyroid-associated orbitopathy. Arch Ophthalmol. 2012;130:319–28.

    Article  PubMed  Google Scholar 

  41. Savar LM, Menghani RM, Chong KK, Garneau HC, Goldberg RA. Eyebrow tissue expansion: an underappreciated entity in thyroid associated orbitopathy. Arch Ophthalmol. 2012;130:1566–9.

    Article  PubMed  Google Scholar 

  42. DeSanto LW, Gorman CA. Selection of patients and choice of operation for orbital decompression in graves ophthalmopathy. Laryngoscope. 1973;83:945–59.

    Article  CAS  PubMed  Google Scholar 

  43. Hurwitz JJ, Birt D. Approach to orbital decompression in Graves’ orbitopathy. Arch Ophthalmol. 1985;103(5):660–5.

    Article  CAS  PubMed  Google Scholar 

  44. Ogura JH. Surgical results of orbital decompression for malignant exophthalmos. J Laryngol Otol. 1978;92(3):181–95.

    Article  CAS  PubMed  Google Scholar 

  45. Borumandi F, Hammer B, Kamer L, von Arx G. How predictable is exophthalmos reduction in Graves’ orbitopathy? A review of the literature. Br J Ophthalmol. 2011;95:1625–30.

    Article  PubMed  Google Scholar 

  46. Leong SC, White PS. Outcomes following surgical decompression for dysthyroid orbitopathy (Graves’ disease). Curr Opin Otolaryngol Head Neck Surg. 2010;18:37–43.

    Article  PubMed  Google Scholar 

  47. Chong KK, Goldberg RA. Lateral canthal surgery. Facial Plast Surg. 2010;26:193–200.

    Article  CAS  PubMed  Google Scholar 

  48. Shorr N, Baylis HI, Goldberg RA, Perry JD. Transcaruncular approach to the medial orbit and orbital apex. Ophthalmology. 2000;107:1459–63.

    Article  CAS  PubMed  Google Scholar 

  49. Long JA, Baylis HI. Hypoglobus following orbital decompression for dysthyroid ophthalmopathy. Ophthal Plast Reconstr Surg. 1990;6:185–9.

    Article  CAS  PubMed  Google Scholar 

  50. Garrity JA, Fatourechi V, Bergstralh EJ, et al. Results of transantral orbital decompression in 428 patients with severe Graves’ ophthalmopathy. Am J Ophthalmol. 1993;116:533–47.

    Article  CAS  PubMed  Google Scholar 

  51. Goldberg RA, Shorr N, Cohen MS. The medical orbital strut in the prevention of postdecompression dystopia in dysthyroid ophthalmopathy. Ophthal Plast Reconstr Surg. 1992;8:32–4.

    Article  CAS  PubMed  Google Scholar 

  52. Alper MG. Pioneers in the history of orbital decompression for Graves’ ophthalmopathy. Doc Ophthalmol. 1995;89:163–71.

    Article  CAS  PubMed  Google Scholar 

  53. Moran RE, Letterman GS, Schurter MA. The surgical correction of exophthalmos. History, technique, and long-term follow-up. Plast Reconstr Surg. 1972;49:595–608.

    Article  CAS  PubMed  Google Scholar 

  54. Kroll AJ, Casten VG. Dysthyroid exophthalmos. Palliation by lateral orbital decompression. Arch Ophthalmol. 1966;76:205–10.

    Article  CAS  PubMed  Google Scholar 

  55. Fichter N, Krentz H, Guthoff RF. Functional and esthetic outcome after bony lateral wall decompression with orbital rim removal and additional fat resection in graves’ orbitopathy with regard to the configuration of the lateral canthal region. Orbit. 2013;32:239–46.

    Article  PubMed  Google Scholar 

  56. Schaaf H, Santo G, Graf M, Howaldt HP. En bloc resection of the lateral orbital rim to reduce exophthalmos in patients with Graves’ disease. J Craniomaxillofac Surg. 2010;38:204–10.

    Article  PubMed  Google Scholar 

  57. Fayers T, Barker LE, Verity DH, Rose GE. Oscillopsia after lateral wall orbital decompression. Ophthalmology. 2013;120(9):1920–3.

    Article  PubMed  Google Scholar 

  58. Goldberg RA, Kim AJ, Kerivan KM. The lacrimal keyhole, orbital door jamb, and basin of the inferior orbital fissure. Arch Ophthalmol. 1998;116:1618–24.

    Article  CAS  PubMed  Google Scholar 

  59. Goldberg RA, Perry JD, Hortaleza V, Tong JT. Strabismus after balanced medial plus lateral wall versus lateral wall only orbital decompression for dysthyroid orbitopathy. Ophthal Plast Reconstr Surg. 2000;16:271–7.

    Article  CAS  PubMed  Google Scholar 

  60. Ben Simon GJ, Schwarcz RM, Mansury AM, Wang L, McCann JD, Goldberg RA. Minimally invasive orbital decompression: local anesthesia and hand-carved bone. Arch Ophthalmol. 2005;123:1671–5.

    Article  PubMed  Google Scholar 

  61. Chang M, Baek S, Lee TS. Long-term outcomes of unilateral orbital fat decompression for thyroid eye disease. Graefes Arch Clin Exp Ophthalmol. 2013;251:935–9.

    Article  PubMed  Google Scholar 

  62. Richter DF, Stoff A, Olivari N. Transpalpebral decompression of endocrine ophthalmopathy by intraorbital fat removal (Olivari technique): experience and progression after more than 3000 operations over 20 years. Plast Reconstr Surg. 2007;120:109–23.

    Article  CAS  PubMed  Google Scholar 

  63. Robert P-YR, Rivas M, Camezind P, Rulfi J-Y, Adenis J-P. Decrease of intraocular pressure after fat-removal orbital decompression in Graves disease. Ophthal Plast Reconstr Surg. 2006;22:92–5.

    Article  PubMed  Google Scholar 

  64. Wu C-H, Chang T-C, Liao S-L. Results and predictability of fat-removal orbital decompression for disfiguring graves exophthalmos in an Asian patient population. Am J Ophthalmol. 2008;145:755–9.

    Article  PubMed  Google Scholar 

  65. Satterfield D, Keltner JL, Morrison TL. Psychosocial aspects of strabismus study. Arch Ophthalmol. 1993;111:1100–5.

    Article  CAS  PubMed  Google Scholar 

  66. Hatt SR, Leske DA, Kirgis PA, Bradley EA, Holmes JM. The effects of strabismus on quality of life in adults. Am J Ophthalmol. 2007;144:643–7.

    Article  PubMed Central  PubMed  Google Scholar 

  67. Bradley EA, Sloan JA, Novotny PJ, Garrity JA, Woog JJ, West SK. Evaluation of the National Eye Institute visual function questionnaire in Graves’ ophthalmopathy. Ophthalmology. 2006;113:1450–4.

    Article  PubMed  Google Scholar 

  68. Kim DB, Meyer DR, Simon JW. Retractor lysis as prophylaxis for lower lid retraction following inferior rectus recession. J Pediatr Ophthalmol Strabismus. 2002;39:198–202.

    PubMed  Google Scholar 

  69. Liao SL, Shih MJ, Lin LL-K. A procedure to minimize lower lid retraction during large inferior rectus recession in graves ophthalmopathy. Am J Ophthalmol. 2006;141:340–5.

    Article  PubMed  Google Scholar 

  70. Meyer DR, Simon JW, Kansora M. Primary infratarsal lower eyelid retractor lysis to prevent eyelid retraction after inferior rectus muscle recession. Am J Ophthalmol. 1996;122:331–9.

    Article  CAS  PubMed  Google Scholar 

  71. Kushner BJ. A surgical procedure to minimize lower-eyelid retraction with inferior rectus recession. Arch Ophthalmol. 1992;110:1011–4.

    Article  CAS  PubMed  Google Scholar 

  72. Chang HS, Lee D, Taban M, Douglas RS, Goldberg RA. “En-glove” lysis of lower eyelid retractors with AlloDerm and dermis-fat grafts in lower eyelid retraction surgery. Ophthal Plast Reconstr Surg. 2011;27:137–41.

    Article  PubMed  Google Scholar 

  73. Holds JB, Anderson RL, Thiese SM. Lower eyelid retraction: a minimal incision surgical approach to retractor lysis. Ophthalmic Surg. 1990;21:767–71.

    CAS  PubMed  Google Scholar 

  74. Lee SJ, Rim THT, Jang SY, et al. Treatment of upper eyelid retraction related to thyroid-associated ophthalmopathy using subconjunctival triamcinolone injections. Graefes Arch Clin Exp Ophthalmol. 2013;251(1):261–70.

    Article  CAS  PubMed  Google Scholar 

  75. Xu D, Liu Y, Xu H, Li H. Repeated triamcinolone acetonide injection in the treatment of upper-lid retraction in patients with thyroid-associated ophthalmopathy. Can J Ophthalmol. 2012;47:34–41.

    Article  CAS  PubMed  Google Scholar 

  76. Aa A, Hussein AM, Ea S. Orbital steroid injection versus oral steroid therapy in management of thyroid-related ophthalmopathy. Clin Experiment Ophthalmol. 2010;38:692–7.

    Article  Google Scholar 

  77. Bordaberry M, Marques DL, Pereira-Lima JC, Marcon IM, Schmid H. Repeated peribulbar injections of triamcinolone acetonide: a successful and safe treatment for moderate to severe Graves’ ophthalmopathy. Acta Ophthalmol. 2009;87:58–64.

    Article  CAS  PubMed  Google Scholar 

  78. Ebner R, Devoto MH, Weil D, et al. Treatment of thyroid associated ophthalmopathy with periocular injections of triamcinolone. Br J Ophthalmol. 2004;88:1380–6.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  79. Goldberg RA. Orbital steroid injections R. Br J Ophthalmol. 2004;88:1359–60.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  80. Costa PG, Saraiva FP, Pereira IC, Monteiro MLR, Matayoshi S. Comparative study of Botox (R) injection treatment for upper eyelid retraction with 6-month follow-up in patients with thyroid eye disease in the congestive or fibrotic stage. Eye (Lond). 2009;23:767–73.

    Article  CAS  Google Scholar 

  81. Morgenstern KE, Evanchan J, Foster JA, et al. Botulinum toxin type A for dysthyroid upper eyelid retraction. Ophthal Plast Reconstr Surg. 2004;20:181–5.

    Article  CAS  PubMed  Google Scholar 

  82. Shih MJ, Liao SL, Lu HY. A single transcutaneous injection with Botox (R) for dysthyroid lid retraction. Eye (Lond). 2004;18:466–9.

    Article  CAS  Google Scholar 

  83. Traisk F, Tallstedt L. Thyroid associated ophthalmopathy: botulinum toxin A in the treatment of upper eyelid retraction—a pilot study. Acta Ophthalmol Scand. 2001;79:585–8.

    Article  CAS  PubMed  Google Scholar 

  84. Uddin JM, Davies PD. Treatment of upper eyelid retraction associated with thyroid eye disease with subconjunctival botulinum toxin injection. Ophthalmology. 2002;109:1183–7.

    Article  PubMed  Google Scholar 

  85. Goldberg RA, Fiaschetti D. Filling the periorbital hollows with hyaluronic acid gel: initial experience with 244 injections. Ophthal Plast Reconstr Surg. 2006;22:335–41. discussion 41-3.

    Article  PubMed  Google Scholar 

  86. Mancini R, Khadavi NM, Goldberg RA. Nonsurgical management of upper eyelid margin asymmetry using hyaluronic acid gel filler. Ophthal Plast Reconstr Surg. 2011;27:1–3.

    Article  PubMed  Google Scholar 

  87. Goldberg RA, Lee S, Jayasundera T, Tsirbas A, Douglas RS, McCann JD. Treatment of lower eyelid retraction by expansion of the lower eyelid with hyaluronic acid gel. Ophthal Plast Reconstr Surg. 2007;23:343–8.

    Article  PubMed  Google Scholar 

  88. Zamani M, Thyagarajan S, Olver JM. Functional use of hyaluronic acid gel in lower eyelid retraction. Arch Ophthalmol. 2008;126:1157–9.

    Article  PubMed  Google Scholar 

  89. Baldeschi L, Wakelkamp IM, Lindeboom R, Prummel MF, Wiersinga WM. Early versus late orbital decompression in Graves’ orbitopathy: a retrospective study in 125 patients. Ophthalmology. 2006;113:874–8.

    Article  PubMed  Google Scholar 

  90. Chang EL, Bernardino CR, Rubin PA. Normalization of upper eyelid height and contour after bony decompression in thyroid-related ophthalmopathy: a digital image analysis. Arch Ophthalmol. 2004;122:1882–5.

    Article  PubMed  Google Scholar 

  91. Ben Simon GJ, Mansury AM, Schwarcz RM, Lee S, McCann JD, Goldberg RA. Simultaneous orbital decompression and correction of upper eyelid retraction versus staged procedures in thyroid-related orbitopathy. Ophthalmology. 2005;112:923–32.

    Article  PubMed  Google Scholar 

  92. Morax S, Hurbli T. Choice of surgical treatment for Graves’ disease. J Craniomaxillofac Surg. 1987;15:174–81.

    Article  CAS  PubMed  Google Scholar 

  93. Tremolada C, Tremolada MA. The “triple technique” for treating stable Graves’ ophthalmopathy. Plast Reconstr Surg. 1997;100:40–8. discussion 9-50.

    Article  CAS  PubMed  Google Scholar 

  94. Norris JH, Ross JJ, O'Reilly P, Malhotra R. A review of combined orbital decompression and lower eyelid recession surgery for lower eyelid retraction in thyroid orbitopathy. Br J Ophthalmol. 2011;95:1664–9.

    Article  PubMed  Google Scholar 

  95. Papageorgiou KI, Ang M, Chang SH, Kohn J, Martinez S, Goldberg RA. Aesthetic considerations in upper eyelid retraction surgery. Ophthal Plast Reconstr Surg. 2012;28:419–23.

    Article  PubMed  Google Scholar 

  96. Goldberg RA, Fiaschetti D. Filling the periorbital hollows with hyaluronic acid gel: initial experience with 244 injections. Ophthal Plast Reconstr Surg. 2006;22:335–41. discussion 41-3.

    Article  PubMed  Google Scholar 

  97. Lambros V. Fat injection for the aging midface. Operative Tech Plast Reconstr Surg. 1998;5:129–37.

    Article  Google Scholar 

  98. Goldberg RA. Transconjunctival orbital fat repositioning: transposition of orbital fat pedicles into a subperiosteal pocket. Plast Reconstr Surg. 2000;105:743–8. discussion 9-51.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Orbital and Ophthalmic Plastic Surgery, Jules Stein Eye Institute, 100 Stein Plaza, Los Angeles, CA, 90095, USA

    Robert A. Goldberg M.D. & Daniel B. Rootman M.Sc., M.D.

Authors
  1. Robert A. Goldberg M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Daniel B. Rootman M.Sc., M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Robert A. Goldberg M.D. .

Editor information

Editors and Affiliations

  1. Division of Eye Plastic, Orbital, and Facial Cosmetic Surgery, Kellogg Eye Center, University of Michigan, Ann Arbor, Michigan, USA

    Raymond S. Douglas

  2. Division of Eye Plastic, Orbital, and Facial Cosmetic Surgery, Kellogg Eye Center, University of Michigan, Ann Arbor, Michigan, USA

    Allison N. McCoy

  3. Division of Eye Plastic, Orbital, and Facial Cosmetic Surgery, Kellogg Eye Center, University of Michigan, Ann Arbor, Michigan, USA

    Shivani Gupta

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media New York

About this chapter

Cite this chapter

Goldberg, R.A., Rootman, D.B. (2015). Noninvasive, Minimally Invasive, and Surgical Pearls for Cosmetic Rejuvenation of the Thyroid Eye Disease Patient. In: Douglas, R., McCoy, A., Gupta, S. (eds) Thyroid Eye Disease. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-1746-4_12

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-1746-4_12

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-1745-7

  • Online ISBN: 978-1-4939-1746-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation